MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets

Endocrine-Related Cancer

Volumn 17, Issue 3, 2010, Pages 835-846

  Meyer Rochow, Goswin Y ^a,c,d   Jackson, Nicole E ^a,c   Conaglen, John V ^d   Whittle, Denis E ^d   Kunnimalaiyaan, Muthusamy ^e   Chen, Herbert ^e   Westin, Gunnar ^f   Sandgren, Johanna ^f   Stålberg, Peter ^f   Khanafshar, Elham ^g   Shibru, Daniel ^g   Duh, Quan Yang ^g   Clark, Orlo H ^g   Kebebew, Electron ^h   Gill, Anthony J ^b,c   Clifton Bligh, Rory ^a,b,c   Robinson, Bruce G ^a,b,c   Benn, Diana E ^a,c   Sidhu, Stan B ^a,b,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c University of Sydney   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; MICRORNA; MICRORNA 15A; MICRORNA 16; MICRORNA 483 5P; REGULATOR PROTEIN; SOMATOMEDIN B; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BENIGN TUMOR; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER SURVIVAL; CELL COUNT; CELL CYCLE REGULATION; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MICROARRAY ANALYSIS; NONHUMAN; PHEOCHROMOCYTOMA; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION PROCESS; WESTERN BLOTTING;

ADRENAL GLAND NEOPLASMS; ADRENAL GLANDS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; COHORT STUDIES; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHEOCHROMOCYTOMA; PROGNOSIS; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 77956387978     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1677/ERC-10-0142     Document Type: Article

References (46)

1. Adler JT, Meyer-Rochow GY, Chen H, Benn DE, Robinson BG, Sippel RS & Sidhu SB 2008 Pheochromocytoma: current approaches and future directions. Oncologist 13 779-793. (doi:10.1634/theoncologist.2008-0043)
2. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T & Vassella E 2009 miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Research 69 5553-5559. (doi:10.1158/0008-5472.CAN-08-4277)
3. Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R, Ramirez N, Abajo A, Navarro A, Moreno I, Monzo M et al. 2006 Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Molecular Cancer 5 29. (doi:10.1186/1476-4598-5-29)
4. Bhattacharya R, Nicoloso M, Arvizo R, Wang E, Cortez A, Rossi S, Calin GA & Mukherjee P 2009 MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer. Cancer Research 69 9090-9095. (doi:10.1158/0008-5472.CAN-09-2552)
5. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C & Croce CM 2007 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Journal of the American Medical Association 297 1901-1908. (doi:10.1001/jama.297.17.1901)
6. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C et al. 2008 The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nature Medicine 14 1271-1277. (doi:10.1038/nm.1880)
7. Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC & Uberti ECD 2005 miR-15a and miR-16-1 downregulation in pituitary adenomas. Journal of Cellular Physiology 204 280-285. (doi:10.1002/jcp.20282)
8. Brouwers FM, Petricoin EF III, Ksinantova L, Breza J, Rajapakse V, Ross S, Johann D, Mannelli M, Shulkin BL, Kvetnansky R et al. 2005 Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. Endocrine-Related Cancer 12 263-272. (doi:10.1677/erc.1.00913)
9. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K et al. 2002 Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. PNAS 99 15524-15529. (doi:10.1073/pnas.242606799)
10. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, Sabatino G, Negrini M, Maira G, Croce CM & Farace MG 2005 Extensive modulation of a set of microRNAs in primary glioblastoma. Biochemical and Biophysical Research Communications 334 1351-1358. (doi:10.1016/j.bbrc.2005.07.030)
11. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M et al. 2005 miR-15 and miR-16 induce apoptosis by targeting BCL2. PNAS 102 13944-13949. (doi:10.1073/pnas.0506654102)
12. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih Ie M, Zhang Y, Wood W III, Becker KG & Morin PJ 2008 MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS ONE 3 e2436. (doi:10.1371/ journal.pone.0002436)
13. DeLellis R, Lloyd R, Heitz P & Eng C 2004 Tumours of the adrenal gland. In WHO Classification of Tumours, Pathology and Genetics of Tumours of Endocrinology, edn 1, pp 147-155. Lyon: IARC Press.
14. 2+ channels in PC12 cells. Cell Calcium 44 339-352. (doi:10.1016/j.ceca.2008.01.007)
15. Engels BM & Hutvagner G 2006 Principles and effects of microRNA-mediated post-transcriptional gene regulation. Oncogene 25 6163-6169. (doi:10.1038/sj.onc.1209909)
16. He H, Jazdzewski K, Li W, Liyanarachchi S, Nagy R, Volinia S, Calin GA, Liu C-G, Franssila K, Suster S et al. 2005 The role of microRNA genes in papillary thyroid carcinoma. PNAS 102 19075-19080. (doi:10.1073/pnas.0509603102)
17. Huang YS, Dai Y, Yu XF, Bao SY, Yin YB, Tang M & Hu CX 2008 Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis. Journal of Gastroenterology and Hepatology 23 87-94. (doi:10.1111/j.1440-1746.2007.05223.x) (Pubitemid 350265207)
18. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H et al. 2007 MicroRNA signatures in human ovarian cancer. Cancer Research 67 8699-8707. (doi:10.1158/0008-5472.CAN-07-1936)
19. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL, Morgan DL, Postier RG, Brackett DJ & Schmittgen TD 2007 Expression profiling identifies microRNA signature in pancreatic cancer. International Journal of Cancer 120 1046-1054. (doi:10.1002/ijc.22394)
20. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG et al. 2008 Altered MicroRNA expression in cervical carcinomas. Clinical Cancer Research 14 2535-2542. (doi:10.1158/1078-0432.CCR-07-1231)
21. Li W, Xie L, He X, Li J, Tu K, Wei L, Wu J, Guo Y, Ma X, Zhang P et al. 2008 Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma. International Journal of Cancer 123 1616-1622. (doi:10.1002/ijc. 23693)
22. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA et al. 2005 MicroRNA expression profiles classify human cancers. Nature 435 834-838. (doi:10.1038/nature03702)
23. Lui WO, Pourmand N, Patterson BK & Fire A 2007 Patterns of known and novel small RNAs in human cervical cancer. Cancer Research 67 6031-6043. (doi:10.1158/0008-5472.CAN-06-0561)
24. Meyer-Rochow GY, Smith JM, Richardson A-L, Marsh DJ, Sidhu SB, Robinson BG & Benn DE 2009 Denaturing high performance liquid chromatography detection of SDHB, SDHD, and VHL germline mutations in pheochromocytoma. Journal of Surgical Research 157 55-62. (doi:10.1016/j.jss.2008.07.043)
25. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T & Shimotohno K 2006 Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25 2537-2545. (doi:10.1038/sj.onc.1209283)
26. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW & Kim S 2008 MicroRNA expression profiles in serous ovarian carcinoma. Clinical Cancer Research 14 2690-2695. (doi:10.1158/1078-0432.CCR-07-1731)
27. Neumann HPH, Bausch B, McWhinney SR, Bender BU, Gimm O, Franke G, Schipper J, Klisch J, Altehoefer C, Zerres K et al. 2002 Germ-line mutations in nonsyndromic pheochromocytoma. New England Journal of Medicine 346 1459-1466. (doi:10.1056/NEJMoa020152)
28. Pallante P, Visone R, Ferracin M, Ferraro A, Berlingieri MT, Troncone G, Chiappetta G, Liu CG, Santoro M, Negrini M et al. 2006 MicroRNA deregulation in human thyroid papillary carcinomas. Endocrine-Related Cancer 13 497-508. (doi:10.1677/erc.1.01209)
29. Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL & Visakorpi T 2007 MicroRNA expression profiling in prostate cancer. Cancer Research 67 6130-6135. (doi:10.1158/0008-5472.CAN-07-0533) (Pubitemid 47037493)
30. Ravenel JD, Broman KW, Perlman EJ, Niemitz EL, Jayawardena TM, Bell DW, Haber DA, Uejima H & Feinberg AP 2001 Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of wilms tumor. Journal of the National Cancer Institute 93 1698-1703. (doi:10.1093/jnci/93.22.1698)
31. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, Holloway A & Smyth GK 2007 A comparison of background correction methods for two-colour microarrays. Bioinformatics 23 2700-2707. (doi:10.1093/bioinformatics/btm412) (Pubitemid 350048334)
32. Roccaro AM, Sacco A, Thompson B, Leleu X, Azab AK, Azab F, Runnels J, Jia X, Ngo HT, Melhem MR et al. 2009 MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma. Blood 113 6669-6680. (doi:10.1182/blood-2009- 01-198408)
33. Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P, Bersani S, Calin GA, Volinia S, Liu CG, Scarpa A et al. 2006 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. Journal of Clinical Oncology 24 4677-4684. (doi:10.1200/JCO.2005.05.5194)
34. Schmitt A, Saremaslani P, Schmid S, Rousson V, Montani M, Schmid DM, Heitz PU, Komminoth P & Perren A 2006 IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours. Histopathology 49 298-307. (doi:10.1111/j.1365-2559.2006.02505.x) (Pubitemid 44253620)
35. Schultz J, Lorenz P, Gross G, Ibrahim S & Kunz M 2008 MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth. Cell Research 18 549-557. (doi:10.1038/cr.2008.45) (Pubitemid 351630945)
36. Soon PSH, Gill AJ, Benn DE, Clarkson A, Robinson BG, McDonald KL & Sidhu SB 2009a Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas. Endocrine-Related Cancer 16 573-583. (doi:10.1677/ERC-08-0237)
37. Soon PSH, Tacon LJ, Gill AJ, Bambach CP, Sywak MS, Campbell PR, Yeh MW, Wong SG, Clifton-Bligh RJ, Robinson BG et al. 2009b miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research 15 7684-7692. (doi:10.1158/1078-0432.CCR-09-1587)
38. Strong VE, Kennedy T, Al-Ahmadie H, Tang L, Coleman J, Fong Y, Brennan M & Ghossein RA 2008 Prognostic indicators of malignancy in adrenal pheochromocytomas: clinical, histopathologic, and cell cycle/apoptosis gene expression analysis. Surgery 143 759-768. (doi:10.1016/j.surg.2008.02.007)
39. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E & Hahn SA 2007 MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 26 4442-4452. (doi:10.1038/sj.onc.1210228) (Pubitemid 47014466)
40. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y et al. 2004 Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Research 64 3753-3756. (doi:10.1158/0008-5472.CAN-04-0637)
41. Takeshita F, Patrawala L, Osaki M, Takahashi R-U, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D et al. 2010 Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes. Molecular Therapy 18 181-187. (doi:10.1038/mt.2009.207)
42. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, Tantoso E, Li KB, Ooi LL, Tan P et al. 2008 Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. Journal of Biological Chemistry 283 13205-13215. (doi:10.1074/jbc.M707629200)
43. Weber F, Teresi RE, Broelsch CE, Frilling A & Eng C 2006 A limited set of human microRNA is deregulated in follicular thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 91 3584-3591. (doi:10.1210/jc.2006-0693) (Pubitemid 44402141)
44. Wong QW, Lung RW, Law PT, Lai PB, Chan KY, To KF & Wong N 2008 MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135 257-269. (doi:10.1053/j.gastro. 2008.04.003) (Pubitemid 351910680)
45. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T et al. 2006 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 189-198. (doi:10.1016/j.ccr. 2006.01.025)
46. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV et al. 2008 MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN. Cancer Research 68 425-433. (doi:10.1158/0008-5472.CAN-07-2488)